These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23335975)

  • 1. MicroRNA-193b enhances tumor progression via down regulation of neurofibromin 1.
    Lenarduzzi M; Hui AB; Alajez NM; Shi W; Williams J; Yue S; O'Sullivan B; Liu FF
    PLoS One; 2013; 8(1):e53765. PubMed ID: 23335975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma.
    Kinoshita T; Nohata N; Hanazawa T; Kikkawa N; Yamamoto N; Yoshino H; Itesako T; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Br J Cancer; 2013 Nov; 109(10):2636-45. PubMed ID: 24091622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
    Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD
    Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma.
    Kinoshita T; Hanazawa T; Nohata N; Kikkawa N; Enokida H; Yoshino H; Yamasaki T; Hidaka H; Nakagawa M; Okamoto Y; Seki N
    Oncotarget; 2012 Nov; 3(11):1386-400. PubMed ID: 23159910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
    Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
    Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.
    Nohata N; Hanazawa T; Kinoshita T; Inamine A; Kikkawa N; Itesako T; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Br J Cancer; 2013 Apr; 108(8):1648-58. PubMed ID: 23558898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-34a-5p functions as a tumor suppressor in head and neck squamous cell cancer progression by targeting Flotillin-2.
    Li X; Zhao S; Fu Y; Zhang P; Zhang Z; Cheng J; Liu L; Jiang H
    Int J Biol Sci; 2021; 17(15):4327-4339. PubMed ID: 34803501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer.
    Koshizuka K; Hanazawa T; Kikkawa N; Arai T; Okato A; Kurozumi A; Kato M; Katada K; Okamoto Y; Seki N
    Cancer Sci; 2017 Aug; 108(8):1681-1692. PubMed ID: 28612520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A.
    Yang Z; He M; Wang K; Sun G; Tang L; Xu Z
    Int J Clin Exp Pathol; 2014; 7(11):7563-70. PubMed ID: 25550792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity protein 1/microRNA-92b forms a feedback loop promoting the migration and invasion of head and neck squamous cell carcinoma.
    Pang P; Fang H; Wu H; Wang S; Liu M; Jin S; Qi Z; Li Z; Liu F; Sun C
    Bioengineered; 2021 Dec; 12(2):11397-11409. PubMed ID: 34905435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
    Koshizuka K; Hanazawa T; Fukumoto I; Kikkawa N; Matsushita R; Mataki H; Mizuno K; Okamoto Y; Seki N
    J Hum Genet; 2017 Jan; 62(1):113-121. PubMed ID: 27169691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cɛ.
    Datta J; Smith A; Lang JC; Islam M; Dutt D; Teknos TN; Pan Q
    Oncogene; 2012 Sep; 31(36):4045-53. PubMed ID: 22158047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-targeting of multiple microRNAs on factor-Inhibiting hypoxia-Inducible factor gene for the pathogenesis of head and neck carcinomas.
    Kao SY; Tsai MM; Wu CH; Chen JJ; Tseng SH; Lin SC; Chang KW
    Head Neck; 2016 Apr; 38(4):522-8. PubMed ID: 25351569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
    Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
    Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation.
    Severino P; Brüggemann H; Andreghetto FM; Camps C; Klingbeil Mde F; de Pereira WO; Soares RM; Moyses R; Wünsch-Filho V; Mathor MB; Nunes FD; Ragoussis J; Tajara EH
    BMC Cancer; 2013 Nov; 13():533. PubMed ID: 24209638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer.
    Saleh AD; Cheng H; Martin SE; Si H; Ormanoglu P; Carlson S; Clavijo PE; Yang X; Das R; Cornelius S; Couper J; Chepeha D; Danilova L; Harris TM; Prystowsky MB; Childs GJ; Smith RV; Robertson AG; Jones SJM; Cherniack AD; Kim SS; Rait A; Pirollo KF; Chang EH; Chen Z; Van Waes C
    Clin Cancer Res; 2019 May; 25(9):2860-2873. PubMed ID: 30723145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-193b-5p Suppresses Pancreatic Cancer Cell Proliferation, Invasion, Epithelial Mesenchymal Transition, and Tumor Growth by Inhibiting eEF2K.
    Gurbuz N; Kahraman N; Sonmez HE; Mokhlis HA; Kosar PA; Ozpolat B
    Anticancer Agents Med Chem; 2022; 22(14):2607-2618. PubMed ID: 35718922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Oncogenic Targets by Tumor-Suppressive
    Koma A; Asai S; Minemura C; Oshima S; Kinoshita T; Kikkawa N; Koshizuka K; Moriya S; Kasamatsu A; Hanazawa T; Uzawa K; Seki N
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma.
    Kinoshita T; Nohata N; Fuse M; Hanazawa T; Kikkawa N; Fujimura L; Watanabe-Takano H; Yamada Y; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Biochem Biophys Res Commun; 2012 Feb; 418(2):378-83. PubMed ID: 22266319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-9 inhibits growth and invasion of head and neck cancer cells and is a predictive biomarker of response to plerixafor, an inhibitor of its target CXCR4.
    Hersi HM; Raulf N; Gaken J; Folarin N; Tavassoli M
    Mol Oncol; 2018 Dec; 12(12):2023-2041. PubMed ID: 29959873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.